The trial realized each its Key endpoints, with semaglutide two.four mg demonstrating statistically substantial and outstanding enhancements in liver fibrosis without any worsening of steatohepatitis, together with resolution of steatohepatitis without having worsening of liver fibrosis in people with MASH in comparison to placebo.oneMounjaro will … Read More